Exhibit 107.1


Calculation of Filing Fee Tables


Form S-3

(Form Type)


GT Biopharma, Inc.

(Exact Name of Registrant as Specified in its Charter)


Table 1: Newly Registered Securities


   Security Type 














Offering Price

Per Unit




Offering Price

  Fee Rate 

Amount of

Registration Fee

Fees to Be Paid  Equity   Common Stock, $0.001 par value per share    457(o)    (1)(2)    (1)(2)    (1)(2)         
   Other   Warrants    457(o)    (1)(2)    (1)(2)    (1)(2)         
   Other   Units    457(o)    (1)(2)    (1)(2)    (1)(2)         
   Unallocated (Universal) Shelf   —      457(o)    (1)(2)    (1)(2)   $ 150,000,000.00 (3)   0.0001102   $ 16,530.00 (3)
Fees Previously Paid                                    
   Total Offering Amounts        $ 150,000,000.00         $ 16,530.00  
   Total Fees Previously Paid                    
   Total Fee Offsets                    
   Net Fee Due                  $ 16,530.00  


(1) There is being registered hereunder such indeterminate number or amount of common stock, warrants and units as may from time to time be issued by the registrant, which collectively shall have an aggregate initial offering price not to exceed $150,000,000.00. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock, warrants and units being registered hereunder include such indeterminate number of shares of common stock, warrants and units as may be issuable by the registrant with respect to the shares being registered hereunder as a result of stock splits, stock dividends or similar transactions.


(2) Pursuant to Instruction 2.A.iii.b of Item 16(b) of Form S-3, this information is not specified as to each class of securities to be registered. There is being registered hereby such indeterminate number of the securities of each identified class as may from time to time be issued at indeterminate prices. Securities registered hereunder may be sold separately, together or in units with other securities registered hereunder.
(3) The proposed maximum aggregate offering price has been estimated solely to calculate the registration fee in accordance with Rule 457(o) under the Securities Act.